Physician profile
Amy E Booth
NPI 1821018714
$1,686.41
in general payments reported to CMS, 2019-2025
17 companies · $88.78 in 2025
The $88.78 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $494 · 2023: $491 · 2024: $399 · 2025: $88.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $358.71 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $318.56 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $173.87 | 2022-2024 | Watchman Flx |
| Abbott Laboratories | $148.59 | 2022-2023 | Mitraclip |
| Bayer Healthcare Pharmaceuticals INC. | $111.75 | 2021-2024 | |
| Amgen INC. | $104.98 | 2023-2024 | Repatha |
| Lexicon Pharmaceuticals, INC. | $81.36 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $73.69 | 2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $69.04 | 2023-2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $52.02 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.91 | 2021-2022 | |
| Pfizer INC. | $36.71 | 2021 | |
| Heartflow, INC. | $30.48 | 2022 | |
| Atricure, INC. | $28.44 | 2024 | |
| Novo Nordisk INC | $17.21 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $14.64 | 2023 | |
| Medtronic, INC. | $14.45 | 2023 | Micra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.